| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T2016 |
Habilitation, residential, waiver; per diem |
138,991 |
14,660 |
$47.63M |
| S5125 |
Attendant care services; per 15 minutes |
273,178 |
11,974 |
$19.71M |
| T1019 |
Personal care services, per 15 minutes, not for an inpatient or resident of a hospital, nursing facility, icf/mr or imd, part of the individualized plan of treatment (code may not be used to identify services provided by home health aide or certified nurse assistant) |
153,861 |
8,232 |
$11.65M |
| M0355 |
|
25,031 |
1,252 |
$5.28M |
| S9125 |
Respite care, in the home, per diem |
34,844 |
7,073 |
$3.83M |
| T2040 |
Financial management, self-directed, waiver; per 15 minutes |
75,254 |
20,596 |
$3.19M |
| T1005 |
Respite care services, up to 15 minutes |
37,680 |
3,132 |
$2.99M |
| T2017 |
Habilitation, residential, waiver; 15 minutes |
34,632 |
1,529 |
$2.89M |
| H2015 |
Comprehensive community support services, per 15 minutes |
29,611 |
1,666 |
$2.49M |
| G0226 |
|
9,392 |
9,391 |
$1.92M |
| M0361 |
|
10,378 |
731 |
$1.58M |
| G6064 |
|
3,234 |
1,094 |
$1.15M |
| M0111 |
|
3,426 |
3,424 |
$655K |
| M0373 |
|
12,780 |
1,069 |
$577K |
| M0241 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency, subsequent repeat doses |
3,934 |
521 |
$436K |
| M0209 |
|
2,152 |
2,151 |
$407K |
| M0145 |
|
1,484 |
381 |
$196K |
| G0227 |
|
1,429 |
1,429 |
$159K |
| G6063 |
|
3,526 |
1,132 |
$131K |
| G0749 |
|
79 |
36 |
$42K |
| M0420 |
|
486 |
36 |
$18K |